Microenvironment May Predict Sustained MRD Negativity in Newly Diagnosed Myeloma

(MedPage Today) -- A study presented at the 2022 American Society of Hematology (ASH) annual meeting examined how changes in the microenvironment correlated with sustained measurable residual disease (MRD) negativity in patients with newly diagnosed...